GHRL and neuroblastoma: In our recent in vitro study, Popelova et al. (Popelová et al. 2018a) demonstrated that Dpr3-ghrelin, a stable ghrelin analogue, protected SH-SY5Y cells (a human-derived neuroblastoma cell line) against methylglyoxal-induced toxicity and apoptosis, indicating its potential utility as a treatment of neurodegenerative disorders.